• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HBV 相关肝细胞癌患者髓源性抑制细胞表达增加。

Increased Expression of Myeloid-Derived Suppressor Cells in Patients with HBV-Related Hepatocellular Carcinoma.

机构信息

Graduate College of Hebei Medical University, Hebei Medical University, Shijiazhuang, Hebei 050017, China.

College of Life Sciences, Hebei Normal University, Shijiazhuang, Hebei 050024, China.

出版信息

Biomed Res Int. 2020 Mar 14;2020:6527192. doi: 10.1155/2020/6527192. eCollection 2020.

DOI:10.1155/2020/6527192
PMID:32258134
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7097855/
Abstract

METHODS

The percentages of MDSCs, IFN--producing CD4 and CD8 T cells in the peripheral blood of HCC patients, chronic hepatitis B (CHB) patients, and healthy controls (HC) were determined by flow cytometry. The serum concentrations of IL-10 and TNF- were determined by ELISA. The association of the percentages of MDSCs with tumor burden, liver function parameters, systemic inflammation-related indexes, and IFN--producing T cells was assessed.

RESULTS

The percentages of MDSCs and PMN-MDSCs were significantly higher in HCC patients than those in CHB patients and HC. The level of MDSCs was correlated with indirect bilirubin and prealbumin, as well as systemic inflammation response index, monocyte/lymphocyte ratio, and monocyte counts. The frequency of IFN--producing CD8 T cells of HCC patients was lower than that of HC. However, there was no relationship between MDSCs and IFN--producing CD8 T cells. The level of IL-10 in HCC patients was significantly higher than that in CHB patients.

CONCLUSION

MDSCs seem to play an important role in the process leading from chronic HBV infection to HCC. Early inhibiting these cells could affect tumor progression.

摘要

方法

采用流式细胞术检测 HCC 患者、慢性乙型肝炎(CHB)患者和健康对照者(HC)外周血中髓系抑制细胞(MDSCs)、IFN--产生的 CD4 和 CD8 T 细胞的百分比。采用 ELISA 法检测血清中白细胞介素-10(IL-10)和肿瘤坏死因子-α(TNF-α)的浓度。评估 MDSCs 百分比与肿瘤负荷、肝功能参数、全身炎症相关指标和 IFN--产生的 T 细胞之间的相关性。

结果

与 CHB 患者和 HC 相比,HCC 患者的 MDSCs 和 PMN-MDSCs 百分比显著升高。MDSCs 水平与间接胆红素和前白蛋白以及全身炎症反应指数、单核细胞/淋巴细胞比值和单核细胞计数相关。HCC 患者 IFN--产生的 CD8 T 细胞的频率低于 HC。然而,MDSCs 与 IFN--产生的 CD8 T 细胞之间没有关系。HCC 患者的 IL-10 水平明显高于 CHB 患者。

结论

MDSCs 似乎在从慢性乙型肝炎病毒感染到 HCC 的发展过程中发挥重要作用。早期抑制这些细胞可能会影响肿瘤的进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0874/7097855/a53123bcf0ec/BMRI2020-6527192.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0874/7097855/836cfa86453b/BMRI2020-6527192.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0874/7097855/c10c5ef85e30/BMRI2020-6527192.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0874/7097855/bea10cb58a0b/BMRI2020-6527192.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0874/7097855/a53123bcf0ec/BMRI2020-6527192.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0874/7097855/836cfa86453b/BMRI2020-6527192.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0874/7097855/c10c5ef85e30/BMRI2020-6527192.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0874/7097855/bea10cb58a0b/BMRI2020-6527192.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0874/7097855/a53123bcf0ec/BMRI2020-6527192.004.jpg

相似文献

1
Increased Expression of Myeloid-Derived Suppressor Cells in Patients with HBV-Related Hepatocellular Carcinoma.HBV 相关肝细胞癌患者髓源性抑制细胞表达增加。
Biomed Res Int. 2020 Mar 14;2020:6527192. doi: 10.1155/2020/6527192. eCollection 2020.
2
Diverse facets of MDSC in different phases of chronic HBV infection: Impact on HBV-specific T-cell response and homing.慢性乙型肝炎感染不同阶段中 MDSC 的多方面表现:对 HBV 特异性 T 细胞应答和归巢的影响。
Hepatology. 2022 Sep;76(3):759-774. doi: 10.1002/hep.32331. Epub 2022 Feb 28.
3
Frequency and Implications of myeloid-derived suppressor cells and lymphocyte subsets in Egyptian patients with hepatitis C virus-related hepatocellular carcinoma.埃及丙型肝炎病毒相关肝细胞癌患者骨髓源性抑制细胞和淋巴细胞亚群的频率及其意义。
J Med Virol. 2019 Jul;91(7):1319-1328. doi: 10.1002/jmv.25428. Epub 2019 Feb 25.
4
Endoplasmic reticulum stress induced LOX-1 CD15 polymorphonuclear myeloid-derived suppressor cells in hepatocellular carcinoma.内质网应激诱导肝癌中 LOX-1+CD15+ 多形核髓源性抑制细胞。
Immunology. 2018 May;154(1):144-155. doi: 10.1111/imm.12876. Epub 2017 Dec 21.
5
Expression and significance of peripheral myeloid-derived suppressor cells in chronic hepatitis B patients.外周髓源性抑制细胞在慢性乙型肝炎患者中的表达及意义。
Clin Res Hepatol Gastroenterol. 2018 Oct;42(5):462-469. doi: 10.1016/j.clinre.2018.04.002. Epub 2018 May 10.
6
Icaritin-induced immunomodulatory efficacy in advanced hepatitis B virus-related hepatocellular carcinoma: Immunodynamic biomarkers and overall survival.茵陈二炔酮诱导的晚期乙型肝炎病毒相关肝细胞癌的免疫调节疗效:免疫动力学生物标志物和总生存期。
Cancer Sci. 2020 Nov;111(11):4218-4231. doi: 10.1111/cas.14641. Epub 2020 Sep 24.
7
Decreased granzyme-B expression in CD11cCD8 T cells associated with disease progression in patients with HBV-related hepatocellular carcinoma.CD11cCD8 T 细胞中颗粒酶-B 表达降低与 HBV 相关肝细胞癌患者疾病进展相关。
Front Immunol. 2023 Jan 31;14:1107483. doi: 10.3389/fimmu.2023.1107483. eCollection 2023.
8
Interleukin-35 Suppresses Interleukin-9-Secreting CD4 T Cell Activity in Patients With Hepatitis B-Related Hepatocellular Carcinoma.白细胞介素-35 抑制乙型肝炎相关肝细胞癌患者分泌白细胞介素-9 的 CD4 T 细胞的活性。
Front Immunol. 2021 Jun 10;12:645835. doi: 10.3389/fimmu.2021.645835. eCollection 2021.
9
[Alterations of IFN-γ and IL-4 of peripheral blood T cells in patients with chronic HBV infection].[慢性乙肝病毒感染患者外周血T细胞中干扰素-γ和白细胞介素-4的变化]
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2016 Feb;32(2):240-4.
10
Myeloid-derived suppressor cells expansion is closely associated with disease severity and progression in HBV-related acute-on-chronic liver failure.髓系来源的抑制细胞扩增与 HBV 相关慢加急性肝衰竭疾病严重程度和进展密切相关。
J Med Virol. 2019 Aug;91(8):1510-1518. doi: 10.1002/jmv.25466. Epub 2019 Apr 4.

引用本文的文献

1
The immunosuppressive role of MDSCs in HCC: mechanisms and therapeutic opportunities.髓源性抑制细胞在肝癌中的免疫抑制作用:机制与治疗机遇
Cell Commun Signal. 2025 Mar 27;23(1):155. doi: 10.1186/s12964-025-02170-7.
2
Delineation of monocytic and early-stage myeloid-derived suppressor cells in the peripheral blood of patients with hepatocarcinoma.肝癌患者外周血中单核细胞及早期髓系来源抑制细胞的鉴定
Int J Cancer. 2025 Jun 15;156(12):2416-2428. doi: 10.1002/ijc.35390. Epub 2025 Mar 7.
3
HDAC1-3 inhibition triggers NEDD4-mediated CCR2 downregulation and attenuates immunosuppression in myeloid-derived suppressor cells.

本文引用的文献

1
Epidemiology and surveillance for hepatocellular carcinoma: New trends.肝癌的流行病学和监测:新趋势。
J Hepatol. 2020 Feb;72(2):250-261. doi: 10.1016/j.jhep.2019.08.025.
2
The CD14HLA-DR Monocyte: An Immunosuppressive Phenotype That Restrains Responses to Cancer Immunotherapy.CD14HLA-DR 单核细胞:一种免疫抑制表型,抑制对癌症免疫治疗的反应。
Front Immunol. 2019 May 22;10:1147. doi: 10.3389/fimmu.2019.01147. eCollection 2019.
3
Receptor-Interacting Protein Kinase 3 Deficiency Recruits Myeloid-Derived Suppressor Cells to Hepatocellular Carcinoma Through the Chemokine (C-X-C Motif) Ligand 1-Chemokine (C-X-C Motif) Receptor 2 Axis.
组蛋白去乙酰化酶1-3抑制作用触发NEDD4介导的CCR2下调,并减弱髓源性抑制细胞中的免疫抑制作用。
Cancer Immunol Immunother. 2025 Feb 1;74(3):81. doi: 10.1007/s00262-024-03931-y.
4
Significance of Immune and Non-Immune Cell Stroma as a Microenvironment of Hepatocellular Carcinoma-From Inflammation to Hepatocellular Carcinoma Progression.免疫和非免疫细胞基质作为肝癌微环境的意义——从炎症到肝癌进展。
Int J Mol Sci. 2024 Sep 24;25(19):10233. doi: 10.3390/ijms251910233.
5
Role of myeloid-derived suppressor cells in chronic brucellosis.髓系来源的抑制性细胞在慢性布鲁氏菌病中的作用。
Front Cell Infect Microbiol. 2024 Jan 30;14:1347883. doi: 10.3389/fcimb.2024.1347883. eCollection 2024.
6
Drug resistance mechanism and reversal strategy in lung cancer immunotherapy.肺癌免疫治疗中的耐药机制及逆转策略
Front Pharmacol. 2023 Sep 19;14:1230824. doi: 10.3389/fphar.2023.1230824. eCollection 2023.
7
Deciphering the roles of myeloid derived suppressor cells in viral oncogenesis.解析髓系来源的抑制细胞在病毒致癌中的作用。
Front Immunol. 2023 Mar 23;14:1161848. doi: 10.3389/fimmu.2023.1161848. eCollection 2023.
8
Immune landscape and immunotherapy of hepatocellular carcinoma: focus on innate and adaptive immune cells.原发性肝癌的免疫图谱和免疫治疗:聚焦固有免疫和适应性免疫细胞。
Clin Exp Med. 2023 Oct;23(6):1881-1899. doi: 10.1007/s10238-023-01015-2. Epub 2023 Feb 11.
9
Recent progress in molecular mechanisms of postoperative recurrence and metastasis of hepatocellular carcinoma.肝细胞癌术后复发转移的分子机制的最新进展。
World J Gastroenterol. 2022 Dec 14;28(46):6433-6477. doi: 10.3748/wjg.v28.i46.6433.
10
Tumor-promoting myeloid cells in the pathogenesis of human oncoviruses: potential targets for immunotherapy.人类致癌病毒发病机制中促肿瘤髓样细胞:免疫治疗的潜在靶点
Cancer Cell Int. 2022 Oct 27;22(1):327. doi: 10.1186/s12935-022-02727-3.
受体相互作用蛋白激酶 3 缺陷通过趋化因子(C-X-C 基序)配体 1-趋化因子(C-X-C 基序)受体 2 轴招募髓源性抑制细胞进入肝细胞癌。
Hepatology. 2019 Nov;70(5):1564-1581. doi: 10.1002/hep.30676. Epub 2019 Jul 17.
4
Hepatitis B e antigen induces the expansion of monocytic myeloid-derived suppressor cells to dampen T-cell function in chronic hepatitis B virus infection.乙肝 e 抗原诱导单核细胞来源的髓样抑制细胞扩增,从而抑制慢性乙型肝炎病毒感染中的 T 细胞功能。
PLoS Pathog. 2019 Apr 18;15(4):e1007690. doi: 10.1371/journal.ppat.1007690. eCollection 2019 Apr.
5
Myeloid-derived suppressor cells induce regulatory T cells in chronically HBV infected patients with high levels of hepatitis B surface antigen and persist after antiviral therapy.髓源性抑制细胞在慢性 HBV 感染、高乙肝表面抗原水平的患者中诱导调节性 T 细胞,并在抗病毒治疗后持续存在。
Aliment Pharmacol Ther. 2019 May;49(10):1346-1359. doi: 10.1111/apt.15226. Epub 2019 Apr 15.
6
Epidemiology and Management of Hepatocellular Carcinoma.原发性肝癌的流行病学和管理。
Gastroenterology. 2019 Jan;156(2):477-491.e1. doi: 10.1053/j.gastro.2018.08.065. Epub 2018 Oct 24.
7
Targeted and Immune-Based Therapies for Hepatocellular Carcinoma.针对肝细胞癌的靶向和免疫治疗。
Gastroenterology. 2019 Jan;156(2):510-524. doi: 10.1053/j.gastro.2018.09.051. Epub 2018 Oct 1.
8
Blocking Monocytic Myeloid-Derived Suppressor Cell Function via Anti-DC-HIL/GPNMB Antibody Restores the Integrity of T Cells from Cancer Patients.通过抗 DC-HIL/GPNMB 抗体阻断单核细胞来源的髓样抑制细胞功能可恢复癌症患者 T 细胞的完整性。
Clin Cancer Res. 2019 Jan 15;25(2):828-838. doi: 10.1158/1078-0432.CCR-18-0330. Epub 2018 Jul 26.
9
Expression and significance of peripheral myeloid-derived suppressor cells in chronic hepatitis B patients.外周髓源性抑制细胞在慢性乙型肝炎患者中的表达及意义。
Clin Res Hepatol Gastroenterol. 2018 Oct;42(5):462-469. doi: 10.1016/j.clinre.2018.04.002. Epub 2018 May 10.
10
The immunology of hepatocellular carcinoma.肝细胞癌的免疫学。
Nat Immunol. 2018 Mar;19(3):222-232. doi: 10.1038/s41590-018-0044-z. Epub 2018 Jan 29.